Ironwood Pharmaceuticals Inc Cash Flow Quality Index
Ironwood Pharmaceuticals Inc cash flow quality index. Ironwood Pharmaceuticals Inc (IRWD) has a Cash Flow Quality Index of 1.14x as of June 2026. Operating cash flow of $58.28 Million exceeds net income of $51.29 Million, indicating high earnings quality where cash backs reported profits. See IRWD FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Ironwood Pharmaceuticals Inc (2019–2025)
Cash flow quality index of Ironwood Pharmaceuticals Inc from 2019 to 2025. Historical Cash Flow Quality Index for Ironwood Pharmaceuticals Inc across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Ironwood Pharmaceuticals Inc (IRWD) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Ironwood Pharmaceuticals Inc Cash Flow Quality Index by Year (2019–2025)
Ironwood Pharmaceuticals Inc cash flow quality index by year from 2019 to 2025. Year-by-year earnings quality comparison for Ironwood Pharmaceuticals Inc. For the full cash flow conversion analysis, see Ironwood Pharmaceuticals Inc (IRWD) cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 5.29x | $127.04 Million | $24.02 Million | ▼ -95.5% |
| 2024 | 117.67x | $103.55 Million | $880.00K | ▲ +7424.7% |
| 2022 | 1.56x | $273.76 Million | $175.06 Million | ▲ +215.5% |
| 2021 | 0.50x | $261.89 Million | $528.45 Million | ▼ -68.8% |
| 2020 | 1.59x | $168.84 Million | $106.18 Million | ▲ +218.8% |
| 2019 | 0.50x | $10.72 Million | $21.50 Million | — |